EA201490220A1 - Композиция и способ лечения hpv - Google Patents
Композиция и способ лечения hpvInfo
- Publication number
- EA201490220A1 EA201490220A1 EA201490220A EA201490220A EA201490220A1 EA 201490220 A1 EA201490220 A1 EA 201490220A1 EA 201490220 A EA201490220 A EA 201490220A EA 201490220 A EA201490220 A EA 201490220A EA 201490220 A1 EA201490220 A1 EA 201490220A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- relates
- compositions
- hpv
- composition
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к лиофилизированным композициям, включающим цидофовир, гидроксипропилметилцеллюлозу (НРМС) или гидроксиэтилцеллюлозу (НЕС) и необязательно пластификатор. В частности, изобретение относится к композициям, которые образуют листообразную пористую твердую матрицу. Изобретение также относится к способам получения данных композиций. Изобретение также относится к композициям для применения при лечении инфекций, вызванных папилломавирусом человека (HPV) и связанных с HPV злокачественных опухолей, в частности HPV поражений и цервикального рака.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161508473P | 2011-07-15 | 2011-07-15 | |
EP11174193 | 2011-07-15 | ||
PCT/EP2012/063796 WO2013010942A1 (en) | 2011-07-15 | 2012-07-13 | Composition and method for treating hpv |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201490220A1 true EA201490220A1 (ru) | 2014-07-30 |
Family
ID=45877205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201490220A EA201490220A1 (ru) | 2011-07-15 | 2012-07-13 | Композиция и способ лечения hpv |
Country Status (12)
Country | Link |
---|---|
US (1) | US9211338B2 (ru) |
EP (1) | EP2731588B1 (ru) |
JP (1) | JP2014520834A (ru) |
KR (1) | KR20140054067A (ru) |
CN (1) | CN103889400A (ru) |
AU (1) | AU2012285969A1 (ru) |
BR (1) | BR112014000877A2 (ru) |
CA (1) | CA2841851A1 (ru) |
CL (1) | CL2014000110A1 (ru) |
EA (1) | EA201490220A1 (ru) |
MX (1) | MX2014000522A (ru) |
WO (1) | WO2013010942A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA201490220A1 (ru) | 2011-07-15 | 2014-07-30 | Фемалон С.П.Р.Л. | Композиция и способ лечения hpv |
US20200253994A1 (en) * | 2019-02-11 | 2020-08-13 | Chemistryrx | Pyrimidine derivative containing compositions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
US8178123B2 (en) * | 2001-08-29 | 2012-05-15 | Femina Pharma Incorporated | Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration |
US8907153B2 (en) * | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
CN1698643A (zh) * | 2005-05-27 | 2005-11-23 | 山东恒瑞医药科技发展有限公司 | 西多福韦脂质体及其制备方法 |
AU2006292507A1 (en) * | 2005-09-15 | 2007-03-29 | Umd, Inc. | A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration |
EP1837020A1 (en) * | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
EA201490220A1 (ru) | 2011-07-15 | 2014-07-30 | Фемалон С.П.Р.Л. | Композиция и способ лечения hpv |
-
2012
- 2012-07-13 EA EA201490220A patent/EA201490220A1/ru unknown
- 2012-07-13 CN CN201280044697.1A patent/CN103889400A/zh active Pending
- 2012-07-13 BR BR112014000877A patent/BR112014000877A2/pt not_active IP Right Cessation
- 2012-07-13 JP JP2014519572A patent/JP2014520834A/ja active Pending
- 2012-07-13 MX MX2014000522A patent/MX2014000522A/es unknown
- 2012-07-13 CA CA2841851A patent/CA2841851A1/en not_active Abandoned
- 2012-07-13 WO PCT/EP2012/063796 patent/WO2013010942A1/en active Application Filing
- 2012-07-13 EP EP12742822.5A patent/EP2731588B1/en active Active
- 2012-07-13 KR KR1020147003884A patent/KR20140054067A/ko not_active Application Discontinuation
- 2012-07-13 US US14/232,529 patent/US9211338B2/en not_active Expired - Fee Related
- 2012-07-13 AU AU2012285969A patent/AU2012285969A1/en not_active Abandoned
-
2014
- 2014-01-15 CL CL2014000110A patent/CL2014000110A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US9211338B2 (en) | 2015-12-15 |
BR112014000877A2 (pt) | 2017-02-21 |
CA2841851A1 (en) | 2013-01-24 |
CN103889400A (zh) | 2014-06-25 |
EP2731588A1 (en) | 2014-05-21 |
EP2731588B1 (en) | 2016-04-06 |
CL2014000110A1 (es) | 2014-10-24 |
MX2014000522A (es) | 2014-05-30 |
US20140170219A1 (en) | 2014-06-19 |
JP2014520834A (ja) | 2014-08-25 |
NZ620042A (en) | 2015-09-25 |
WO2013010942A1 (en) | 2013-01-24 |
KR20140054067A (ko) | 2014-05-08 |
AU2012285969A1 (en) | 2014-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123739T1 (el) | Αντισωματα anti-cd38 | |
JOP20200307A1 (ar) | جزيئات ربط ضد bcma واستخداماتها | |
EP3584251A3 (en) | Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines | |
TN2012000161A1 (en) | Spiro-oxindole mdm2 antagonists | |
EA201391719A1 (ru) | Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
MX340830B (es) | Vacuna neumococica y usos de la misma. | |
EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
CO6480995A2 (es) | Construcciones novedosas de proteina del virus de pailoma humano (hpv) y su uso en la prevencion de la enfermedad por el hpv | |
TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
AR088514A1 (es) | Inmunoligantes biespecificos dirigidos contra tnf | |
UA113956C2 (xx) | Похідні піримідину для лікування вірусних інфекцій | |
EP4230641A3 (en) | Human cd30 ligand antigen binding proteins | |
MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
NZ708016A (en) | Lyophilized preparations of melphalan flufenamide | |
MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
BR112013030150A2 (pt) | proteína l1 hpv33 truncada ou variante da mesma, ácido nucléico isolado, vetor, célula hospedeira, partícula do tipo viral hpv33, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv33 truncada, método para preparar a partícula do tipo viral hpv33, método para preparar uma vacina, método para prevenir a infecção hpv ou uma doença causada pela infecção de hpv e uso da proteína l1 hpv33 truncada ou variante da mesma | |
CY1118704T1 (el) | Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου | |
WO2017192418A8 (en) | Therapeutic hpv vaccine combinations | |
PH12015502589A1 (en) | 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives | |
EA201490220A1 (ru) | Композиция и способ лечения hpv | |
AU2014286128B2 (en) | Human anti-IL-32 antibodies | |
MX2013003859A (es) | Polimorfos de picropodofilina b o c para su uso en la terapia del cancer. | |
MX360449B (es) | Vacunas para el virus del papiloma humano y metodos para su uso. |